VBI Vaccines Inc.
VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, coronaviruses, and cytomegalovirus (CMV), as well as aggressive cancers including glioblastoma (GBM). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Pharmaceuticals
- Market Focus:
- Globally (various continents)
About Us
- We are a company driven by immunology in the pursuit of powerful prevention and treatment of disease
- Our vision is to stimulate and amplify the human immune system to target and overcome significant infectious diseases and aggressive cancers
- Our belief in the importance of protecting and enhancing human life is at the core of everything we do
When properly stimulated, the human immune system is incredibly powerful and has profound potential. Because of their structural similarity to viruses presented in nature, virus-like particles (VLPs) are ideal for stimulating potent immune responses. Most of the emerging and re-emerging viruses that pose significant health threats are enveloped viruses, making them a prime target for VBI’s proprietary enveloped virus-like particle (eVLP) platform technology.
VBI is a global biopharmaceutical company, with corporate headquarters in Cambridge, MA, United States, research and development facilities in Ottawa, Canada, and a research and manufacturing facility in Rehovot, Israel.
Activating the Power Within
Driven by Immunology in the Pursuit of Powerful Prevention and Treatment of Disease
Our Philosophy: Immune to Limitations
At VBI, we believe that by stimulating and fortifying the immune system, we can overcome even the toughest public health and medical challenges.
With deep roots in immunology and vaccinology, we are committed to better health for all.
Our Focus: Infectious Disease and Cancer
Our pipeline candidates are working to address significant unmet public health and medical needs – from a highly-contagious infectious disease putting hundreds of millions of people at risk worldwide, to a fast-growing cancer that typically results in death within 15 months of diagnosis.
We are committed to the fight.
Our Pipeline: Both Sides of the Fight
VBI’s pipeline of vaccine and immunotherapeutic candidates are designed to power the human immune system to both prevent and fight disease.
Prevention
Vaccines prepare our bodies to fight disease, playing a crucial role in keeping us healthy.
Treatment
Immunotherapeutics help to harness and direct the immune system’s natural defenses to eliminate infections and diseased cells.